David White

Insider profile

Performance

Overall performance
2.1

Performance over holding periods
2.1
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Principal Accounting Officer, Vice President - Finance Five Prime Therapeutics Inc Feb. 28, 2019 - Dec. 1, 2019
Vice President - Finance Five Prime Therapeutics Inc Feb. 25, 2019 - Feb. 28, 2019

David White's trades of Fevara PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-01-29 2024-01-26 B Purchase
61,487
131.72
£2,662,830
61,487 131.72 £2,662,830
2023-05-19 2023-05-17 B Purchase
4,275
317.83
£3,540,060
4,275 317.83 £3,540,060